IMMU - Immunomedics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $96.88. This is a potential upside of $9.02 (10.27%) from yesterday's end of day stock price of $87.86.

Immunomedics's activity chart (see below) currently has 92 price targets and 54 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 95.83% with an average time for these price targets to be met of 171.1 days.

Most recent stock forecast was given by CHRIS HOWERTON from JEFFERIES on 15-Sep-2020. First documented stock forecast 29-Jul-2015.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$55

4 years 3 months 17 days ago
(15-Sep-2020)

5/6 (83.33%)

$11.69 (26.99%)

66

Hold

$56

4 years 3 months 18 days ago
(14-Sep-2020)

8/8 (100%)

$14.84 (36.05%)

163

$40

$-47.86 (-54.47%)

$19

4 years 4 months 22 days ago
(10-Aug-2020)

5/5 (100%)

$-0.92 (-2.25%)

252

Buy

$55

$-32.86 (-37.40%)

$45

4 years 4 months 26 days ago
(06-Aug-2020)

9/9 (100%)

$11.82 (27.37%)

107

Buy

$55

$-32.86 (-37.40%)

$52

4 years 4 months 26 days ago
(06-Aug-2020)

5/5 (100%)

$11.82 (27.37%)

173

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is IMMU (Immunomedics) average time for price targets to be met?

On average it took 171.1 days on average for the stock forecasts to be realized with a an average price target met ratio 95.83

Which analyst has the current highest performing score on IMMU (Immunomedics) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the most public recommendations on IMMU (Immunomedics)?

Raghuram Selvaraju has 3 price targets and 17 ratings on IMMU

Which analyst is the currently most bullish on IMMU (Immunomedics)?

Raghuram Selvaraju with highest potential upside - $0

Which analyst is the currently most reserved on IMMU (Immunomedics)?

Matthew Andrews with lowest potential downside - -$65.86

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?